/

Companies / Deuteroncology

Deuteroncology

Liege, Belgium

Deuteroncology is developing a deuterated MET kinase inhibitor as a potential targeted therapy for MET driven disease

Deuteroncology, based in Liege, Belgium, has 2 investors on file, among them Newton Biocapital and Noshaq. Its site was last checked 13 Nov 2026: site answers.

Investors

2 investors on file
InvestorEvidenceType
Newton BiocapitalPortfolio pageVenture capital
NoshaqPortfolio pageInvestor

More from Newton Biocapital

13 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (100%).

See Newton Biocapital's full profile · Who invests alongside it

More from Noshaq

186 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (23%), AI & Machine Learning (19%), Industrial & Manufacturing (13%).

See Noshaq's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Deuteroncology and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Newton Biocapital adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/deuteroncology.com/investors

# also
GET /v1/companies/deuteroncology.com
GET /v1/companies/deuteroncology.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing